why choose us

Clinical Trials Search

Showing 7,490 of 132,963 result(s)
A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)

Status: Completed

Condition: Non-segmental Vitiligo

Interventions: MK-6194 administered subcutaneously (SC)

Date: 2023-10-27

Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome Decompression

Status: Completed

Condition: Recurrent Cubital Tunnel Syndrome

Interventions: Axoguard HA+ Nerve Protector™ is a surgical implant that provides non-constricting protection for non-transected peripheral nerve injuries where there

Date: 2023-10-27

Study of AZD9829 in CD123+ Hematological Malignancies

Status: NOT_YET_RECRUITING

Condition: Hematological Malignancies

Interventions: AZD9829 will be administered by IV infusion

Date: 2023-10-27

A Study of TAK-279 in Healthy Chinese Adults

Status: COMPLETED

Condition: Healthy Volunteers

Interventions: TAK-279 oral tablet.

Date: 2023-10-27

Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A;B for the Production of BabyBIG®

Status: COMPLETED

Condition: Botulism

Interventions: Recombinant Botulinum Vaccine A;B, rBV A;B

Date: 2023-10-27

Testing a Barbershop-based HIV Prevention Initiative Among Men

Status: COMPLETED

Condition: HIV Infections

Interventions: General, status-neutral HIV education

Date: 2023-10-27

Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A;B for the Production of BabyBIG®

Status: COMPLETED

Condition: Botulism

Interventions: Recombinant Botulinum Vaccine A;B, rBV A;B

Date: 2023-10-27

CellFX ® Percutaneous Electrode (PE) Treatment of Symptomatic Benign Thyroid Nodules

Status: COMPLETED

Condition: Thyroid Nodule (Benign)

Interventions: Percutaneous treatment with CellFX® Percutaneous Electrode using nanosecond pulse field ablation (nsPFA) technology

Date: 2023-10-26

Assess Efficacy and Safety of a Nasal Spray in Adults With Dry or Irritated Nose

Status: COMPLETED

Condition: Dry Nose

Interventions: One or two nasal sprays will be administered to each nostril for a minimum of 2 times per day up to a maximum of 6 times per day for seven days.

Date: 2023-10-26

Oxygen Delivery Methods of Nasal Catheter on the Incidence of Hypoxemia in Patients with Painless Gastroscopy

Status: COMPLETED

Condition: Hypoxemia

Interventions: After the implantation of the mirror, nasal catheter was used to give oxygen through the mouth

Date: 2023-10-26